Prof. Martin Eilers to get 1.5 milion euro funding by German Cancer Aid

01/19/2022

Excellence Funding Programme for Established Scientists

On the left, you can see microscopic images of tumour and normal tissue, showing that triggering collisions between reading and doubling DNA leads to chrosomosomal breaks and death of tumour tissue, but has no effects on neighbouring normal tissue. On the right, radiological images show that the tumour collapses after a relatively short treatment. The images show neuroblastomas. (Images: AG Eilers)

Prof. Eilers holds the Chair of Biochemistry and Molecular Biology at the Julius-Maximilians-Universität Würzburg (JMU) and is a renowned cancer researcher. For many years, together with his team, he has been investigating the factors that control organismal cell growth and cell division in the organism, as well as the processes that are responsible for the dysfunction of there factors in tumour cells. "Our research aims to understand how these factors work and how they are regulated in order to use this knowledge for new tumour therapy strategies," says Eilers.

Prof. Eilers can now pursue this goal in a new project that the German Cancer Aid is financing with 1.5 million euros over the next five years. "High Risk – High Gain": This is the motto of the new "Excellence Funding Programme for Established Scientists" of the German Cancer Aid. It is specifically used to support particularly innovative, but also "daring" projects, or – in other words: "Scientific projects that bring the chance of a significant gain in knowledge and thus have the potential to decisively advance cancer medicine," as Gerd Nettekoven, Chairman of the Board of the German Cancer Aid, says.

Weblink: Präsentation der sechs Projekte bei der Deutschen Krebshilfe

Prof. Dr. Martin Eilers, Lehrstuhl für Biochemie und Molekularbiologie, T: +49 931 31-84111, martin.eilers@biozentrum.uni-wuerzburg.de

Full text in german by Gunnar Bartsch

Back